ThinkGenetic is excited to announce that Amazon Web Services, Inc. (AWS), a subsidiary of Amazon.com, Inc., has approved ThinkGenetic into it’s AWS Activate program.
Amazon Web Services provides startups with infrastructure needed to scale and grow businesses. AWS Activate is a program designed to provide startups with resources they need to get started on AWS. ThinkGenetic has been granted $100,000 in AWS Promotional Credit for 1 year, 1 year of AWS Business Support, Access to the AWS Technical and Business Essentials web-based (or instructor-led) training, and credits for Self-Paced Labs.
When asked about inclusion in AWS Activate ThinkGenetic CEO, Dave Jacob said, “We are incredibly grateful to AWS for offering such a program to startups. All of us at ThinkGenetic are amazed at their generosity as well as the amazing work of our advocates at MassChallenge. It was one of the best decisions we made to apply and participate in this accelerator.”
ThinkGenetic was announced as a finalist in the startup accelerator program, MassChallenge, in January 2018 and has since been provided with incredible opportunity. In addition to having dedicated industry champions, like Shire plc (LSE: SHP, NASDAQ: SHPG) and Massachusetts eHealth Institute (MeHI), and mentors, MassChallenge has provided unique opportunities to its partners driving success for all the startup participants.
“It’s always exciting when we can help startups with the key elements of their businesses,” explains MassChallenge Program Director, Nick Dougherty. “Sometimes that manifests in the partnerships ThinkGenetic generates with organizations like Shire and MeHI. Sometimes that manifests in solutions like AWS that help their business operate. Both scenarios are necessary to solve massive challenges and ThinkGenetic does so well for people with genetic diseases.”
Moving forward the web service costs for ThinkGenetic will be covered for one year. This is the perfect time as SymptomMatcherTM, ThinkGenetic’s new artificial intelligence (AI)-driven diagnostic aid to support finding patients with select rare genetic diseases and shorten the time to diagnosis genetic conditions, is expanding in order to include even more genetic conditions.
We encourage you to keep an eye on the developments of ThinkGenetic and SymptomMatcher by signing up for email updates. To subscribe please click here.